Similar articles for PMID: 21233022

Year	Number of Results
1999	1
2000	3
2001	3
2002	3
2003	6
2004	3
2005	2
2006	2
2007	2
2008	3
2009	12
2010	10
2011	12
2012	7
2013	7
2014	6
2015	2
2016	6
2017	2
2018	3
2019	5
2020	2
2021	3
2022	1
2023	1
2024	0

1

Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.

Dhodapkar MV, Richter J. Dhodapkar MV, et al. Clin Immunol. 2011 Aug;140(2):160-6. doi: 10.1016/j.clim.2010.12.010. Epub 2011 Jan 12. Clin Immunol. 2011. PMID: 21233022 Free PMC article. Review.

2

Harnessing CD1d-restricted T cells toward antitumor immunity in humans.

Neparidze N, Dhodapkar MV. Neparidze N, et al. Ann N Y Acad Sci. 2009 Sep;1174:61-7. doi: 10.1111/j.1749-6632.2009.04931.x. Ann N Y Acad Sci. 2009. PMID: 19769737 Free PMC article.

3

Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.

Singh AK, Rhost S, Löfbom L, Cardell SL. Singh AK, et al. Scand J Immunol. 2019 Sep;90(3):e12794. doi: 10.1111/sji.12794. Epub 2019 Jun 26. Scand J Immunol. 2019. PMID: 31141185 Free PMC article.

4

Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.

Rzemieniak SE, Hirschfeld AF, Victor RE, Chilvers MA, Zheng D, van den Elzen P, Turvey SE. Rzemieniak SE, et al. Immunology. 2010 Jun;130(2):288-95. doi: 10.1111/j.1365-2567.2009.03234.x. Epub 2010 Jan 19. Immunology. 2010. PMID: 20102408 Free PMC article.

5

Application of natural killer T cells in antitumor immunotherapy.

Hong C, Park SH. Hong C, et al. Crit Rev Immunol. 2007;27(6):511-25. doi: 10.1615/critrevimmunol.v27.i6.20. Crit Rev Immunol. 2007. PMID: 18197797 Review.

6

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.

Hong S, Lee H, Jung K, Lee SM, Lee SJ, Jun HJ, Kim Y, Song H, Bogen B, Choi I. Hong S, et al. Immunol Lett. 2013 Nov-Dec;156(1-2):132-9. doi: 10.1016/j.imlet.2013.10.002. Epub 2013 Oct 19. Immunol Lett. 2013. PMID: 24148970

7

Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.

Almeida CF, Smith DGM, Cheng TY, Harpur CM, Batleska E, Nguyen-Robertson CV, Nguyen T, Thelemann T, Reddiex SJJ, Li S, Eckle SBG, Van Rhijn I, Rossjohn J, Uldrich AP, Moody DB, Williams SJ, Pellicci DG, Godfrey DI. Almeida CF, et al. Proc Natl Acad Sci U S A. 2021 Aug 24;118(34):e2104420118. doi: 10.1073/pnas.2104420118. Proc Natl Acad Sci U S A. 2021. PMID: 34417291 Free PMC article.

8

NKT and tolerance.

Diana J, Beaudoin L, Gautron AS, Lehuen A. Diana J, et al. Methods Mol Biol. 2011;677:193-206. doi: 10.1007/978-1-60761-869-0_14. Methods Mol Biol. 2011. PMID: 20941612

9

Human NKT cells express granulysin and exhibit antimycobacterial activity.

Gansert JL, Kiessler V, Engele M, Wittke F, Röllinghoff M, Krensky AM, Porcelli SA, Modlin RL, Stenger S. Gansert JL, et al. J Immunol. 2003 Mar 15;170(6):3154-61. doi: 10.4049/jimmunol.170.6.3154. J Immunol. 2003. PMID: 12626573

10

Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.

Papoutselis M, Spanoudakis E. Papoutselis M, et al. Clin Lymphoma Myeloma Leuk. 2020 Jun;20(6):358-365. doi: 10.1016/j.clml.2020.01.006. Epub 2020 Mar 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32234294 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year